SeaStar Medical


SeaStar Medical is a medical technology company focused on redefining extracorporeal therapies to mitigate the effects of excessive inflammation on vital organs. Their innovative solutions, particularly the Selective Cytopheretic Device (SCD), aim to improve outcomes for critically ill patients by addressing dysregulated immune responses that can lead to severe complications such as acute kidney injury and multi-organ failure.

SeaStar Medical

SeaStar Medical

3513 Brighton Blvd, Suite 410, Denver, CO 80216


Patents

Cytopheresis cartridges and use thereof

2024-01-09 • US-11866730-B2

View Details

Cartridge and method for increasing myocardial function

2022-09-13 • US-11439739-B2

View Details

Cytopheresis cartridges and use thereof

2021-09-14 • US-11118162-B2

View Details

Cartridge and method for increasing myocardial function

2020-07-28 • US-10722637-B2

View Details

Cartridge and method for increasing myocardial function

2020-06-30 • US-10695482-B2

View Details

Selective cytopheresis devices and related methods thereof

2016-11-22 • US-9498566-B2

View Details

What We Do

A patented cell-directed extracorporeal therapy designed to target and neutralize activated neutrophils and monocytes, which are key immune cells involved in hyperinflammation. The SCD aims to restore immune balance and improve patient outcomes in critically ill patients.

A humanitarian medical device for treating pediatric patients with acute kidney injury (AKI) due to sepsis or septic conditions. It is FDA approved and integrates with existing hemodialysis systems.



Key People

Eric Schlorff

Chief Executive Officer

LinkedIn

David Green

Chief Financial Officer

LinkedIn

Kevin Chung, M.D.

Chief Medical Officer

LinkedIn

Sai P. Iyer, Ph.D.

Senior Vice President, Medical Affairs & Research

LinkedIn

Tom Mullen

Vice President, Operations & Product Development

LinkedIn

Tim Varacek

Senior Vice President, Commercial & Business Operations

LinkedIn

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.